N-[5-[3-[7-(4-methylimidazol-1-yl)-3H-imidazo[4,5-c]pyridin-2-yl]-7-[1-methyl-4-[2-[5-[5-(propanoylamino)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperazin-2-yl]-2H-indazol-5-yl]-3-pyridinyl]cyclohexanecarboxamide
C55H52N18O2 — CID 137028963
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[3-[7-(4-methylimidazol-1-yl)-3H-imidazo[4,5-c]pyridin-2-yl]-7-[1-methyl-4-[2-[5-[5-(propanoylamino)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperazin-2-yl]-2H-indazol-5-yl]-3-pyridinyl]cyclohexanecarboxamide
N-[5-[3-[7-(4-methylimidazol-1-yl)-3H-imidazo[4,5-c]pyridin-2-yl]-7-[1-methyl-4-[2-[5-[5-(propanoylamino)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperazin-2-yl]-2H-indazol-5-yl]-3-pyridinyl]cyclohexanecarboxamide (PubChem CID 137028963) has the molecular formula C55H52N18O2 and a molecular weight of 997.14 g/mol. Its IUPAC name is N-[5-[3-[7-(4-methylimidazol-1-yl)-3H-imidazo[4,5-c]pyridin-2-yl]-7-[1-methyl-4-[2-[5-[5-(propanoylamino)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperazin-2-yl]-2H-indazol-5-yl]-3-pyridinyl]cyclohexanecarboxamide.
Molecular Properties
| Compound Name | N-[5-[3-[7-(4-methylimidazol-1-yl)-3H-imidazo[4,5-c]pyridin-2-yl]-7-[1-methyl-4-[2-[5-[5-(propanoylamino)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperazin-2-yl]-2H-indazol-5-yl]-3-pyridinyl]cyclohexanecarboxamide |
|---|---|
| PubChem CID | 137028963 |
| Molecular Formula | C55H52N18O2 |
| Molecular Weight | 997.14 g/mol |
| Exact Mass | 996.45 |
| IUPAC Name | N-[5-[3-[7-(4-methylimidazol-1-yl)-3H-imidazo[4,5-c]pyridin-2-yl]-7-[1-methyl-4-[2-[5-[5-(propanoylamino)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperazin-2-yl]-2H-indazol-5-yl]-3-pyridinyl]cyclohexanecarboxamide |
| SMILES | CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCN(C)C(c7cc(-c8cncc(NC(=O)C9CCCCC9)c8)cc8c(-c9nc%10c(-n%11cnc(C)c%11)cncc%10[nH]9)[nH]nc78)C6)cncc5[nH]4)c3c2)c1 |
| InChI | InChI=1S/C55H52N18O2/c1-4-47(74)61-36-14-34(19-56-21-36)32-10-11-41-38(16-32)49(69-67-41)53-63-42-23-58-25-44(51(42)65-53)72-13-12-71(3)46(28-72)39-17-33(35-15-37(22-57-20-35)62-55(75)31-8-6-5-7-9-31)18-40-48(39)68-70-50(40)54-64-43-24-59-26-45(52(43)66-54)73-27-30(2)60-29-73/h10-11,14-27,29,31,46H,4-9,12-13,28H2,1-3H3,(H,61,74)(H,62,75)(H,63,65)(H,64,66)(H,67,69)(H,68,70) |
| InChIKey | GJUZJOLKRTWVHE-UHFFFAOYSA-N |
| XLogP | 9.29 |
| TPSA | 248.78 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 75 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 997.14 |
| LogP ≤ 5 | 9.29 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137028963 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.